| Product Code: ETC13378551 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Type 2 Diabetes Drugs and Devices Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Type 2 Diabetes Drugs and Devices Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Type 2 Diabetes Drugs and Devices Market Revenues & Volume, 2021 & 2031F |
3.3 North America Type 2 Diabetes Drugs and Devices Market - Industry Life Cycle |
3.4 North America Type 2 Diabetes Drugs and Devices Market - Porter's Five Forces |
3.5 North America Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 North America Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.8 North America Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.9 North America Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 North America Type 2 Diabetes Drugs and Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Type 2 Diabetes Drugs and Devices Market Trends |
6 North America Type 2 Diabetes Drugs and Devices Market, 2021 - 2031 |
6.1 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Oral Drugs, 2021 - 2031 |
6.1.3 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Injectables, 2021 - 2031 |
6.1.4 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Insulin Therapy, 2021 - 2031 |
6.1.5 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Combination Therapy, 2020 - 2028 |
6.2 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Metformin, 2021 - 2031 |
6.2.3 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By SGLT2 Inhibitors, 2021 - 2031 |
6.2.4 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By GLP-1 Agonists, 2021 - 2031 |
6.2.5 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By DPP-4 Inhibitors, 2021 - 2031 |
6.3 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Glucose Monitors, 2021 - 2031 |
6.3.3 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Insulin Pumps, 2021 - 2031 |
6.3.4 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By CGMs, 2021 - 2031 |
6.3.5 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Smart Insulin Pens, 2021 - 2031 |
6.4 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By End Use, 2021 - 2031 |
6.4.2 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.4 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Pharmacies, 2020 - 2028 |
6.4.5 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Home Care, 2020 - 2028 |
7 North America Type 2 Diabetes Drugs and Devices Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United States (US) Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Canada Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Rest of North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 North America Type 2 Diabetes Drugs and Devices Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
7.3.1 United States (US) Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3.2 Canada Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3.3 Rest of North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.4 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.4.1 United States (US) Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.4.2 Canada Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.4.3 Rest of North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.5 North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5.1 United States (US) Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5.2 Canada Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5.3 Rest of North America Type 2 Diabetes Drugs and Devices Market, Revenues & Volume, By End Use, 2021 - 2031 |
8 North America Type 2 Diabetes Drugs and Devices Market Key Performance Indicators |
9 North America Type 2 Diabetes Drugs and Devices Market - Export/Import By Countries Assessment |
10 North America Type 2 Diabetes Drugs and Devices Market - Opportunity Assessment |
10.1 North America Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 North America Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10.4 North America Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By Device Type, 2021 & 2031F |
10.5 North America Type 2 Diabetes Drugs and Devices Market Opportunity Assessment, By End Use, 2021 & 2031F |
11 North America Type 2 Diabetes Drugs and Devices Market - Competitive Landscape |
11.1 North America Type 2 Diabetes Drugs and Devices Market Revenue Share, By Companies, 2022 |
11.2 North America Type 2 Diabetes Drugs and Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here